Clinical and laboratory parameters in the differential diagnosis of pleural effusion secondary to tuberculosis or cancer

被引:30
作者
Antonangelo, Leila [1 ]
Vargas, Francisco Suso [2 ]
Seiscento, Marcia [2 ]
Bombarda, Sidney [2 ]
Teixera, Lisete [2 ]
Barbosa de Sales, Roberta Karla [2 ]
机构
[1] Univ Sao Paulo, Sch Med,Hosp Clin, Serv Cytol, Div Cent Lab, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Hosp Clin, Heart Inst Incor, Sao Paulo, Brazil
关键词
pleural effusion; neoplasm; tuberculosis; adenosine deaminase; exudates;
D O I
10.1590/S1807-59322007000500009
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
PURPOSE: To evaluate the clinical and laboratory characteristics of pleural effusions secondary to tuberculosis (TB) or cancer (CA). METHODS: A total of 326 patients with pleural effusion due to TB (n=182) or CA (n=144) were studied. The following parameters were analyzed: patient gender, age and pleural effusion characteristics (size, location, macroscopic fluid aspect, protein concentration, lactate dehydrogenase (DHL) and adenosine deaminase activity (ADA) and nucleated cell counts). RESULTS: Young male patients predominated in the tuberculosis group. The effusions were generally moderate in size and unilateral in both groups. Yellow-citrine fluid with higher protein (p < 0.001) levels predominated in effusions from the tuberculosis group (5.3 +/- 0.8 g/dL) when compared to the CA group (4.2 +/- 1.0 g/dL), whereas DHL levels were more elevated in CA (1,177 +/- 675 x 1,030 +/- 788 IU; p = 0.003) than in TB. As expected, ADA activity was higher in the TB group (107.6 +/- 44.2 x 30.6 +/- 57.5 U/L; p < 0.001). Both types of effusions presented with high nucleated cell counts, which were more pronounced in the malignant group (p < 0.001). TB effusion was characterized by a larger percentage of leukocytes and lymphocytes (p < 0.001) and a smaller number of mesothelial cells (p = 0.005). Lymphocytes and macrophages were the predominant nucleated cell in neoplastic effusions. CONCLUSION: Our results demonstrate that in lymphocytic pleural exudate obtained from patients with clinical and radiological evidence of tuberculosis, protein and ADA were the parameters that better characterize these effusions. In the same way, when the clinical suspicion is malignancy, serous-hemorrhagic lymphocytic fluid should be submitted to oncotic cytology once this easy and inexpensive exam reaches a high diagnostic performance (congruent to 80%). In this context, we suggest thoracocentesis with fluid biochemical and cytological examination as the first diagnostic approach for these patients.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 26 条
[1]
ANTONANGELO L, 2001, ASPECTOS CLIN LAB DE, P135
[2]
ANTUNES G, 2003, THORAX S2, V58, P29, DOI DOI 10.1136/THORAX.58.SUPPL_2.II29
[3]
Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions [J].
Castro, DJ ;
Nuevo, GD ;
Pérez-Rodríguez, E ;
Light, RW .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) :220-224
[4]
Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy [J].
Chen, ML ;
Yu, WC ;
Lam, CW ;
Au, KM ;
Kong, FY ;
Chan, AYW .
CLINICA CHIMICA ACTA, 2004, 341 (1-2) :101-107
[5]
Diagnostic tools in tuberculous pleurisy: a direct comparative study [J].
Diacon, AH ;
Van de Wal, BW ;
Wyser, C ;
Smedema, JP ;
Bezuidenhout, J ;
Bolliger, CT ;
Walzl, G .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :589-591
[6]
DIBONITO L, 1992, ACTA CYTOL, V36, P329
[7]
Tuberculous effusion: ADA activity correlates with CD4+cell numbers in the fluid and the pleura [J].
Gaga, M ;
Papamichalis, G ;
Bakakos, P ;
Latsi, P ;
Samara, I ;
Koulouris, NG ;
Alchanatis, N ;
Orphanidou, D .
RESPIRATION, 2005, 72 (02) :160-165
[8]
Giusti G., 1974, Methods of Enzymatic Analysis, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0
[9]
Diagnosis and treatment of tuberculous pleural effusion in 2006 [J].
Gopi, Arun ;
Madhavan, Sethu M. ;
Sharma, Surendra K. ;
Sahn, Steven A. .
CHEST, 2007, 131 (03) :880-889
[10]
Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis [J].
Goto, M ;
Noguchi, Y ;
Koyama, H ;
Hira, K ;
Shimbo, T ;
Fukui, T .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :374-381